comparemela.com

Latest Breaking News On - Renaissance paris nobel tour eiffel hotel - Page 1 : comparemela.com

Onxeo S A : Onxeo: Combined General Meeting of June 6, 2023: Availability of Preparatory Documents and Participation & Voting Procedures

Regulatory News: Onxeo S.A. (Euronext Growth Paris: ALONX), a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA Damage Response (DDR) and

France generalOnxeo sa euronextOnis onxeoArthur rouillNicolas fossiezGewinn nurRaymond poincarRenaissance paris nobel tour eiffel hotelCompany groupRegulatory newsEuronext growth parisCombined general meetingGeneral meetingGeneral meetingsInvestor relations

Onxeo S A : Onxeo: Extraordinary General Meeting of February 6, 2023: Availability of Preparatory Documents

Regulatory News: Onxeo S.A. (Euronext Growth Paris: ALONX), hereafter "Onxeo" or the "Company", a clinical stage biotechnology company specializing in the development of innovative drugs targeting

France generalArthur rouillOnis onxeoRaymond poincarOnxeo sa euronextEmmanuel huynhRenaissance paris nobel tour eiffel hotelCompany groupRegulatory newsEuronext growth parisExtraordinary general meetingGeneral meetingGeneral meetings

Onxeo S A : Onxeo Announces a Combined General Meeting on August 17, 2022

Regulatory News: Onxeo S.A. (Euronext Growth Paris: ALONX, Nasdaq First North Copenhagen: ONXEO), hereafter "Onxeo" or the "Company", a clinical-stage biotechnology company specializing in the development

France generalArthur rouillRaymond poincarOnxeo sa euronextEmmanuel huynhRenaissance paris nobel tour eiffel hotelCompany groupRegulatory newsEuronext growth parisNasdaq first north copenhagenCombined general meetingMandatory legal noticesNasdaq first northEuronext growthGeneral meetingssectionInvestor relations

vimarsana © 2020. All Rights Reserved.